chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I have a condition known as Spinal Stenosis. Diagnosed 3years ago. If creates alternating pain in neck, shoulders and upper arms, mostly on my right side. I had the shot in my left arm. The next morning at 10:00 AM, I started having spasms in my upper right arm that continued for 6 hours. I have never had anything like this happen before. It was completely debilitating. I sat for hours with heating pad on neck and arm. It was so painful I had tears in my eyes for most of the day. I slept on and off while heat treating it. Then after about 6 hours it stopped. The next day the muscles in that area were sore.
Vial was pulled from the fridge but not diluted before dose was pulled up into syringe.
He woke the morning after finishing pill #2 of a 4 dose series of oral typhoid with a solid itchy red rash under both arms and in armpits. The night prior to rash onset, he had 2-3 mosquito bites on shoulder and back.
Information has been received from a certified medical assistant (C.M.A.) concerning a patient who on 03-JAN-2011 was inadvertently vaccinated subcutaneously with a 0.5 ml dose of VARIVAX (Merck) instead of ZOSTAVAX (Merck). No adverse effect reported. It was unknown if the patient sought a medical attention. Additional information has been requested.
pale, diaphoresis, tightness in throat Narrative: Patient lost consciousness for ~2 minutes ~11 mins after covid vaccination. Witness observed patient arching her back and non responsive. patient was safely lowered to floor. vitals BP 99/52 HR 62 R 18 97RA. patient was pale and diaphoretic. code team was called at 11:42 epi pen was administered. as patient began to come to she was very confused. code team arrived to transfer patient to ED.
Four hours after vaccination, I developed arm pain at site of injection and below toward the insertion point of the deltoid and was unable to abduct or extend my shoulder -- I think this was actually an inability to abduct the arm, but the severe pain was certainly a limiting factor. I applied ice, which gave temporary relief of pain, but did not affect pain with attempted motion. I also had pain radiating to the back of my hand, in the "webbing" between my thumb and first finger. About 16 hours after vaccination, I noticed mild redness and tenderness lateral to injection site, but that disappeared after a few hours. I never had redness at the injection site or induration or swelling. I was unable to use my left arm for 3 1/2 days. On day four I had full range of motion of that arm, pain remained, although much diminished. (The pain on days 4-7 was similar to what I've experienced in the first 24 hours after other vaccinations in the past.) From week two through today, I have had full range of motion and no pain EXCEPT for vague nerve pain a couple of times a day that lasts less than a minute, perhaps precipitated by certain movements of that arm.
Discomfort at injection site, fatigue, body aches , headache, chills(6 hrs) fever 12 hrs
Pt experienced swelling (baseball sized) redness spreading from injection site (left shoulder), sleeplessness, nausea, the night of receiving Pneumovax 23 and Fluzone HD...pt took ibuprofen 8/30/16 which relieved swelling but redness remains over entire shoulder area as of 8/31/16 AM, also takes daily Claritin.
Swelling and erythema of left deltoid ?cellulitis- Keflex.
Initial unsolicited report received from a pharmacist on 09-Dec-2016. This case involves 71 year old a female patient who was vaccinated with a dose of FLUZONE HD (Batch number- UI741AB, expiration date- 14-Jun-2017 (dose and dose in series not reported) intramuscularly in left deltoid on 08-Dec-2016 at 02:00 PM. Patient's medical history was reported that pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) reported as none. Illness at the time of vaccination was reported as no. Concomitant medications were not reported. Any other vaccinations within four weeks of vaccinations were also not reported. On 08-Dec-2016, at 08:00 PM six hours after vaccination patient developed swollen eyelids and bloodshot eyes. Laboratory investigations reported as none. Corrective treatment were not reported. It was reported that patient was not recovered from the events. List of documents held by sender: none.
Day 1-3 fever. At first, 100.8F, then Monday, 101.8F. Tuesday normal temp.   Vomiting on day 3.  Not able to eat. Able to drink. No medical care needed yet. Given compazine on day 4.   Missed work 3 days.
received the vaccine Monday afternoon, Tuesday afternoon started getting a knot, redness with the skin warm at the injection site, Wednesday morning the redness was three time larger, Thursday night another line of redness developed underneath, Benadryl has not helped.  it's now Friday and there has been no change.
When I got my next period, my usual are from 5-6 days, but this lasted 8 days and it was much heavier of a period. That continued to happen every month and they got longer and heavier each month. I went to see my doctor - I was there August 19th and I got the implant on Sept 16. I was recommended to take birth control with an implant to try to control the bleeding.  Ever since I was vaccinated ( and my husband, too) - ears are ringing the whole time since having it. I have  had some kind of very unnoticeable ringing in my ears in the past but now they are ringing very loudly. If I don't have some kind of noise to mask it out, it's really annoying. I have had the implant for 2 1/2 weeks now - I got it the same day as I started my period. I had a period that lasted 13 days so I don't know how it's going to go next month.
not receiving 2nd dose; didn't feel well; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (not receiving 2nd dose) and MALAISE (didn't feel well) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (not receiving 2nd dose) and MALAISE (didn't feel well). At the time of the report, PRODUCT DOSE OMISSION ISSUE (not receiving 2nd dose) and MALAISE (didn't feel well) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment and concomitant medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Nov-2021: Non-significant follow-up-received on 16-Nov-2021 and contains NNI
Had a headache; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 14th June 2022, the patient received the 2nd dose of Shingles vaccine. On 14th June 2022, less than a day after receiving Shingles vaccine, the patient experienced headache. On an unknown date, the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the headache to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 14-MAY-2022 Reporter's Comments: This case was received from the patient via interactive digital media. The patient received 2nd dose of Shingles vaccine and experienced headache. The patient wanted to know if he/she could take Tylenol for headache. Additional supportive information: The follow-up would not possible as no contact details were available.
Information has been received from a nurse practitioner referring to a 24 year old female patient. The patient had no concurrent or historical condition. The patient intramuscularly received the first and second doses of GARDASIL 9 (strength, dose, lot number and expire date unknown) on 04-MAY-2016 and 16-JUN-2016, respectively. Concomitant therapy included XULANE. On 16-JUN-2016, the patient experienced an adverse event while on GARDASIL 9 therapy. Prior to receiving the second dosage, she was given a urine test to ascertain pregnancy, and after receiving the vaccine, then it was discovered that she was pregnant. The last menstrual period (LMP) and estimated due date (EDD) were not provided. The outcome of events was unknown. The causality was not provided. Additional information has been requested.
Patient is not having any adverse events at this time other than the medication error.; she inadvertently gave a patient a dose of PROQU AD and a dose of V ARlV AX.; Proquad administered IM; Varivax administered IM; This spontaneous report was received from a medical assistant referring to a 4-year-old female patient. Information regarding the patient's pertinent medical history, concomitant therapies, drug reactions, or allergies was not reported.     On 26-JUL-2021 the patient was vaccinated with Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live rHA (recombinant human albumin)(PROQUAD) (lot number: T028297, which has been verified to be a valid lot number, and expiration date reported and established as: 16-FEB-2022) that was administered intramuscularly (IM) on the left thigh (incorrect route of product administration) (dose and vaccination scheme frequency were not reported) as prophylaxis. On the same day the patient also was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (lot number: T025945, which has been verified to be a valid lot number, and expiration date reported and established as: 30-JUL-2022) that was administered IM on the left thigh (incorrect route of product administration) (dose and vaccination scheme frequency were not reported) as prophylaxis (inappropriate schedule of product administration). In addition on the same date the patient was vaccinated with diphteria vaccine toxoid, pertussis vaccine acellular 5-component, polio vaccine inact 3V (MRC 5), tetanus vaccine toxoid (QUADRACEL) (lot number: C5851AA, expiration date: 25-MAR-2023) administered IM on the right thigh (dose and vaccination scheme frequency were not reported) as prophylaxis. It was reported that the vaccines were administered at the private doctor's office/hospital, purchased with private funds and no digital data logger was involved. The patient did not experience any additional reaction.
headache, nausea, light sensitivity, neck pain, general not feeling well, not sleeping well
1/2hr p/vax face turned red, hives apparent, n/v, severe h/a, vision affected;saw MD & was hosp WBC & segs elevated;Annual follow-up received on 10/13/00 states that the pt has recovered.
Dizziness, malaise....he planned to go home and rest.  He will let us know if he has anymore problem.
Tinnitus, pressue, fullness in both ears, loss of hearing. Took Musinex D for about a week. Followed up with Dr. on 5/17/22.  Prescribed short term treatment of Prednisone.
Diarrhea x 2-3 weeks starting 8 days after rotavirus vaccine. Stool PCR checked after 14 days of diarrhea and it was positive for rotavirus A and norovirus. We are having a norovirus outbreak locally, but unclear how much rotavirus vaccine played a roll as well.
patient reported to  Hospital 2 days later to the ER and had 5 blood clots.  Was treated with Heparin for PE. This incident was patient reported to us.
Information has been received from a registered nurse referring to a patient of unknown age and gender. No relevant medical history or concurrent conditions were reported. On 06-OCT-2015 the patient was vaccinated with 0.5 ml improperly stored (Oka/Merck) VARIVAX lot # L010145, expiration date 24-MAR-2017) via subcutaneous. No adverse effects were reported. Additional information has been requested.
The following day I had pretty severe body aches, headaches, some nausea, and fatigue. I had a constant, sometimes pulsating pain and ache everywhere but especially in my hips and knees. My sciatic nerve seemed to be affected. Treated all day with tylenol and nauzene, which didnt fix it completely but at least made it more bearable. This is the second day following the second dose and I still feel these symptoms some but they are improved, so I'm suspecting no doctor appointment will be needed and it will get better on it's own.
A 17 year old female pt had received in IM, left deltoid, first dose injection of Menactra, lot number U2004AA, on 6/5/06. One day later, the pt developed a fever of 101.5 deg F, achiness, fatigue and soreness at the site. The event did not require examination, and no diagnostic test were performed. At the time of this report, recovery status was unknown.
I received the dose at 1:45 pm on 1/13/2021 at Medical Center. Almost 1 hour post vaccine I started to feel a lump in my throat, as the minutes passed my throat started to feel tighter and fight and flight mode kicked in.  It was hard to swallow, my tongue was swelling and I called EMS at 2:40 pm 1/13/2021.  EMS noticed hives on my chest and left arm where I got the first dose of Moderna.  I received epinephrine IM and IV benadryl in the ambulance.  I was sinus tachycardic with heart rate in the 140s oxygen was 99% room air, lungs clear..  I was taken to ER where I was on observation for 2 hours. I was discharged around 5:10 pm on 1/13/2021.  On my car ride home around 5:40pm I again started to feel my throat tighten, tongue swell, and heart race.  I called EMS again, and was treated with IV benadryl, and epinephrine IM.  I was taken to Medical Center where I was given IV solu-medrol and got blood taken and a pregnancy test done.  My potassium was 3.1 and I took 2 potassium tablets to supplement.  My EKG was normal sinus tach, oxygen 100% room air, blood pressure 140s/90s and got down to 120/80s.  I was transported to another Medical Center for overnight observation because first Medical Center was full.
Pain in arm; Stiffness in arm; swollen fingers/ swollen hands; puffy face; This is a spontaneous report received from a contactable consumer (patient). A 79-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number: unknown, Expiration date was not reported), via an unspecified route of administration on 22Mar2021 at 15:20 (at the age of 79-years-old) as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that, on an unspecified date in 2021, the patient experienced pain in arm, stiffness in arm, swollen fingers, swollen hand, puffy face. The consumer stated that, yesterday, on 22Mar2021, she went to get the first dose of the Pfizer vaccine around 03:20pm and when she got home there was no problem. Stated that, she went to bed at 11pm and woke up at 02:30am with pain in her arm, it was stiff and swollen. Stated that, her hand was swollen, fingers were swollen and her face was a little puffy. Stated that, initially she had swelling in her arm but clarified that, she had pain in her arm and not swelling. Only her hand, fingers and face were swollen and puffy. Stated that, she was scared to take the second shot and enquired, whether that was a normal reaction. The swelling lasted for 4 hours and now it was normal. At 06:30 am, she was already normal. Stated that, the pain was no problem. The swelling scared her. This was on her left side. Stated that, everybody that she heard of had something. Stated that, she knows everyone had a reaction or small problem with stiffness. No other details were provided. Stated that, her son said maybe she should not take the second dose and to call and inquire about this. She asked whether the second dose was safe and if she can take it or not. Stated that, she asked whether that would be safe. Stated that, she can deal with the puffiness. Everybody had issues in their arms, it was like having Covid. Stated that, she only called to ask whether it was normal and safe to take. The outcome of the events for swollen fingers/ swollen hands was recovered on an unspecified date in 2021 while for the other events was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained.  No further information is expected.
It was reported that a male pt who was HIV (+) was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. The pt was also receiving monthly injections of IM, immune serum globulin. Subsequently, the pt experienced vaccine failure and approx. 1 year, post vax, he presented to the hospital with pneumococcal bacteremia. On the basis of a review of blood culture logs at the hospital microbiology lab and of the infectious disease service consultation log between 5/89 and 3/91, it was noted that the clinical course and serotype-specific functional humoral response to S. pneumoniae in 16 HIV-infected pts with pneumococcal bacteremia, and that there was no history of either pneumococcal infection or immunization in any of the 13 pts. No details about the serotype of the organism and immune status of the host were provided. It was noted that sera obtained from HIV (-) adults vaccinated with a 23-valent vaccine showed increased in vitro killing activity against certain S. pneumoniae isotypes when compared with the sera of HIV (+) pts with actual pneumococcal infections. It was noted that although serologic dx may be unreliable in HIV-infected persons, no pt tested showed serologic evidence of recent viral infection. In conclusion, the findings suggested that the high rates of cells and impaired humoral responses to S. pneumoniae rather than to increased exposure to the organism. The report did not state the outcome of the pt's experience. No further information is available.
Information has been received from a RN concerning a 62 yr old white male referee with no known allergies, atrial fibrillation and hypertension who on 01Sep04 was vaccinated SC in the left deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot647029/0460P). There were no adverse events following prior vaccinations. On 03Sep04 at 16:15 the pt developed cellulitis with redness, induration and edema from the shoulder to the armpit. Unspecified medical attention was sought. No diagnostic studies were performed. Subsequently the pt recovered. No product quality complaint was involved. The reporter felt that cellulitis was related to therapy with pneumococcal 23v polysaccharide vaccine. No further information is expected.
Pt came to clinic and received Tdap, MCV4, and HPV #1. Pt fainted after administration. did not lose conscious. Pt was alerted and oriented X3. BP 125/71, P 72, BP 114/73, P73, BP 108/65, P87. Pt left the clinic walking in stable condition. Advised mom to see pcp for further evaluation.
First headache followed shortly by uncontrollable chills and muscle twitching.  Fell asleep and woke about an hour or two later with 102 fever.  By morning fever had broken, no more twitching but developed cough and copious mucus.  Mucus and cough remain, although slightly less, 3 months later.  Woke morning after vaccine nauseaus which passed by around 4 pm, but returned each morning for a few days.  Body, particularly joint pain began within days of vaccine and remain intermittently 3 months later.  Reactivate fibromyalgia?  Tightness in chest, as if I can't take a deep breath remain intermittently, maybe once a week,  3 months later.
I took the first dose of Pfizer Vaccine on 4/6/21 and there was just sore arm for next two days as symptoms and a little  bit of  blue spot at the injection site which went away in next two days and I didn't experience anything post that. I have been experiencing similar kind of mild pain since 4/29 in the vaccine arm while moving my arm up and down or on rotation. I have my second doe scheduled for 5/4 .  Please let me know if this is ok.
Patient vaccinated with 2 dose series at recommended intervals apart.  Was hospitalized with weakened immune system weeks later.  Hospitalization lasted 3weeks, still to this day my immune system is compromised and my WBCs are low.  I have had no medical conditions or weakened immune system my whole life.
rash/red hives; breaking out on both arms; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (rash/red hives) and RASH (breaking out on both arms) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced URTICARIA (rash/red hives) and RASH (breaking out on both arms). At the time of the report, URTICARIA (rash/red hives) and RASH (breaking out on both arms) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient confirmed that she is taking other medications; list not provided.  Treatment provided with alcohol on arms and washing with cold water.
10/02/02 -Saw MD at ER , Left leg "tripled in size", red, hot to touch; ERMD Dx as cellulitis , prescribed Keflex; 10/03/02 - Saw private pediatrician Dx: vaccine reaction; 10/04/02 - Leg improving still swollen, redness decreasing
(R) thigh rash approximately 10 x 7 cm with induration, tender to palpation, swelling. Rash expanding from origin of vaccination out.
Approx 15 min after vaccination, pt developed chest pain, left arm pain/numbness, tongue numbness, feeling faint, itching all over.
expected pain at injection site, so it was not surprising to get it; really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (really bad headache) and VACCINATION SITE PAIN (expected pain at injection site, so it was not surprising to get it) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030H21B) for COVID-19 vaccination.     The patient's past medical history included Tension headaches (Usually, if she gets a headache, it's been tension headaches that gets better with food or sleep.). Previously administered products included for COVID-19 vaccination: PFIZER BIONTECH COVID-19 VACCINE (2nd dose) and PFIZER BIONTECH COVID-19 VACCINE (1st dose). Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE. Concurrent medical conditions included Headache.    On 10-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jan-2022, the patient experienced HEADACHE (really bad headache). On an unknown date, the patient experienced VACCINATION SITE PAIN (expected pain at injection site, so it was not surprising to get it). At the time of the report, HEADACHE (really bad headache) had not resolved and VACCINATION SITE PAIN (expected pain at injection site, so it was not surprising to get it) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pain assessment: 6 out of 10 6 out of 10.         Concomitant medication of the patient was not reported.   She received the booster shot in the afternoon and the headache started in the evening. It got slightly better and then got worse and was persisting. It was not getting better. It was unlike any other headaches she had ever had. Nothing seemed to work for this headache. It was not really debilitating, but definitely affected her. The patient did not try any medication yet.